Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
The promise of pharmacoepidemiology in helping clinicians assess drug risk.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The promise of pharmacoepidemiology in helping clinicians assess drug risk.
Avorn J. The promise of pharmacoepidemiology in helping clinicians assess drug risk. Circulation. 2013 Aug 13; 128(7):745-8.
View in:
PubMed
subject areas
Administration, Oral
Anticoagulants
Atrial Fibrillation
Benzimidazoles
beta-Alanine
Decision Making
Evidence-Based Medicine
Hemorrhage
Humans
Male
Middle Aged
Morpholines
Pharmacoepidemiology
Product Surveillance, Postmarketing
Pyrazoles
Pyridones
Randomized Controlled Trials as Topic
Research Design
Risk Assessment
Therapeutic Equivalency
Thiophenes
United States
United States Food and Drug Administration
Warfarin
authors with profiles
Jerome Lewis Avorn, M.D.